The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 2231.e7-2231.e14

  Kara, Eleanna ^a   Ling, Helen ^a   Pittman, Alan M ^a   Shaw, Karen ^a   de Silva, Rohan ^a   Simone, Roberto ^a   Holton, Janice L ^a   Warren, Jason D ^b   Rohrer, Jonathan D ^b   Xiromerisiou, Georgia ^a   Lees, Andrew ^a   Hardy, John ^a   Houlden, Henry ^a   Revesz, Tamas ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Corticobasal degeneration; Genetics; MAPT; Parkinsonism; Postencephalitic parkinsonism

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; EXON; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; MICROTUBULE ASSOCIATED PROTEIN TAU GENE; MUTATOR GENE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TAUOPATHY;

EID: 84863445909     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.04.006     Document Type: Article

References (30)

1. Ahmed Z., Josephs K.A., Gonzalez J., DelleDonne A., Dickson D.W. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 2008, 131:460-472.
2. Andreadis A., Brown W.M., Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry 1992, 31:10626-10633.
3. Augustinack J.C., Sanders J.L., Tsai L.H., Hyman B.T. Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles. J. Neuropathol. Exp. Neurol 2002, 61:557-564.
4. Braak H., Del Tredici K., Rüb U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
5. Calne D.B., Lees A.J. Late progression of post-encephalitic Parkinson's syndrome. Can. J. Neurol. Sci 1988, 15:135-138.
6. Caparros-Lefebvre D., Steele J., Kotake Y., Ohta S. Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins. Mov. Disord 2006, 21:1769-1771.
7. Conrad C., Andreadis A., Trojanowski J.Q., Dickson D.W., Kang D., Chen X., Wiederholt W., Hansen L., Masliah E., Thal L.J., Katzman R., Xia Y., Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol 1997, 41:277-281.
8. Cruchaga C., Chakraverty S., Mayo K., Vallania F.L., Mitra R.D., Faber K., Williamson J., Bird T., Diaz-Arrastia R., Foroud T.M., Boeve B.F., Graff-Radford N.R., St Jean P., Lawson M., Ehm M.G., Mayeux R., Goate A.M. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012, 7:e31039.
9. de Silva R., Lashley T., Gibb G., Hanger D., Hope A., Reid A., Bandopadhyay R., Utton M., Strand C., Jowett T., Khan N., Anderton B., Wood N., Holton J., Revesz T., Lees A. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol. Appl. Neurobiol 2003, 29:288-302.
10. Economo C.v. Encephalitis Lethargica: Its Sequelae and Treatment 1931, Oxford University Press, London.
11. Geddes J.F., Hughes A.J., Lees A.J., Daniel S.E. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 1993, 116:281-302.
12. Höglinger G.U., Melhem N.M., Dickson D.W., Sleiman P.M., Wang L.S., Klei L., Rademakers R., de Silva R., Litvan I., Riley D.E., van Swieten J.C., Heutink P., Wszolek Z.K., Uitti R.J., Vandrovcova J., Hurtig H.I., Gross R.G., Maetzler W., Goldwurm S., Tolosa E., Borroni B., Pastor P., Cantwell L.B., Han M.R., Dillman A., van der Brug M.P., Gibbs J.R., Cookson M.R., Hernandez D.G., Singleton A.B., Farrer M.J., Yu C.E., Golbe L.I., Revesz T., Hardy J., Lees A.J., Devlin B., Hakonarson H., Muller U., Schellenberg G.D. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet 2011, 43:699-705.
13. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Adamson J., Lees A.J., Rossor M.N., Quinn N.P., Kertesz A., Khan M.N., Hardy J., Lantos P.L., St George-Hyslop P., Munoz D.G., Mann D., Lang A.E., Bergeron C., Bigio E.H., Litvan I., Bhatia K.P., Dickson D., Wood N.W., Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001, 56:1702-1706.
14. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
15. Hyman B.T., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Carrillo M.C., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., Nelson P.T., Schneider J.A., Thal D.R., Thies B., Trojanowski J.Q., Vinters H.V., Montine T.J. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012, 8:1-13.
16. Ince P.G., Clark B., Holton J.L., Revesz T., Wharton S.B. Disorders of movement and system degenerations. Greenfield's Neuropathology 2008, 889-1030. Hodder Arnold, London. S. Love, D.N. Louis, D. Ellison (Eds.).
17. Jicha G.A., Lane E., Vincent I., Otvos L., Hoffmann R., Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem 1997, 69:2087-2095.
18. Kovacs G.G., Wöhrer A., Ströbel T., Botond G., Attems J., Budka H. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clin. Neuropathol 2011, 30:3-10.
19. Litvan I., Hauw J.J., Bartko J.J., Lantos P.L., Daniel S.E., Horoupian D.S., McKee A., Dickson D., Bancher C., Tabaton M., Jellinger K., Anderson D.W. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J. Neuropathol. Exp. Neurol 1996, 55:97-105.
20. Mattila P., Togo T., Dickson D.W. The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease. Neurosci. Lett 2002, 320:81-85.
21. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
22. Momeni P., Pittman A., Lashley T., Vandrovcova J., Malzer E., Luk C., Hulette C., Lees A., Revesz T., Hardy J., de Silva R. Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation. Neurobiol. Aging 2009, 30:388-393.
23. Paisán-Ruíz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
24. Pittman A.M., Myers A.J., Duckworth J., Bryden L., Hanson M., Abou-Sleiman P., Wood N.W., Hardy J., Lees A., de Silva R. The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet 2004, 13:1267-1274.
25. Rademakers R., Cruts M., van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum. Mutat 2004, 24:277-295.
26. Steele J.C. Parkinsonism-dementia complex of Guam. Mov. Disord 2005, 20(Suppl 12):S99-S107.
27. Tan E.K., Peng R., Teo Y.Y., Tan L.C., Angeles D., Ho P., Chen M.L., Lin C.H., Mao X.Y., Chang X.L., Prakash K.M., Liu J.J., Au W.L., Le W.D., Jankovic J., Burgunder J.M., Zhao Y., Wu R.M. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum. Mutat 2010, 31:561-568.
28. Witman G.B., Cleveland D.W., Weingarten M.D., Kirschner M.W. Tubulin requires tau for growth onto microtubule initiating sites. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:4070-4074.
29. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
30. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073. 1000 Genomes Project Consortium.